Conti-Fine BM[au] - Search Results

Year	Number of Results
1995	11
1996	4
1997	8
1998	16
1999	4
2000	5
2001	5
2002	5
2003	9
2004	3
2006	2
2007	2
2008	1
2009	1
2022	0

1

Myasthenia gravis: past, present, and future.

Conti-Fine BM, Milani M, Kaminski HJ. Conti-Fine BM, et al. J Clin Invest. 2006 Nov;116(11):2843-54. doi: 10.1172/JCI29894. J Clin Invest. 2006. PMID: 17080188 Free PMC article. Review.

2

CD4+ T cells and cytokines in the pathogenesis of acquired myasthenia gravis.

Conti-Fine BM, Milani M, Wang W. Conti-Fine BM, et al. Ann N Y Acad Sci. 2008;1132:193-209. doi: 10.1196/annals.1405.042. Ann N Y Acad Sci. 2008. PMID: 18567869 Review.

3

T cell recognition of the acetylcholine receptor in myasthenia gravis.

Conti-Fine BM, Navaneetham D, Karachunski PI, Raju R, Diethelm-Okita B, Okita D, Howard J Jr, Wang ZY. Conti-Fine BM, et al. Ann N Y Acad Sci. 1998 May 13;841:283-308. doi: 10.1111/j.1749-6632.1998.tb10936.x. Ann N Y Acad Sci. 1998. PMID: 9668248 Review. No abstract available.

4

Binding of native kappa-neurotoxins and site-directed mutants to nicotinic acetylcholine receptors.

Chiappinelli VA, Weaver WR, McLane KE, Conti-Fine BM, Fiordalisi JJ, Grant GA. Chiappinelli VA, et al. Among authors: conti fine bm. Toxicon. 1996 Nov-Dec;34(11-12):1243-56. doi: 10.1016/s0041-0101(96)00110-9. Toxicon. 1996. PMID: 9027980 Review.

5

Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity?

Conti-Fine BM, Navaneetham D, Lei S, Maus AD. Conti-Fine BM, et al. Eur J Pharmacol. 2000 Mar 30;393(1-3):279-94. doi: 10.1016/s0014-2999(00)00036-4. Eur J Pharmacol. 2000. PMID: 10771024 Review.

6

CD4+ T cells specific for factor VIII as a target for specific suppression of inhibitor production.

Reding MT, Wu H, Krampf M, Okita DK, Diethelm-Okita BM, Key NS, Conti-Fine BM. Reding MT, et al. Among authors: conti fine bm. Adv Exp Med Biol. 2001;489:119-34. doi: 10.1007/978-1-4615-1277-6_11. Adv Exp Med Biol. 2001. PMID: 11554586 Review.

7

CD4+ T cell response to factor VIII in hemophilia A, acquired hemophilia, and healthy subjects.

Reding MT, Wu H, Krampf M, Okita DK, Diethelm-Okita BM, Key NS, Conti-Fine BM. Reding MT, et al. Among authors: conti fine bm. Thromb Haemost. 1999 Aug;82(2):509-15. Thromb Haemost. 1999. PMID: 10605744 Review.

8

CD4+ T and B cells cooperate in the immunoregulation of Experimental Autoimmune Myasthenia Gravis.

Milani M, Ostlie N, Wu H, Wang W, Conti-Fine BM. Milani M, et al. Among authors: conti fine bm. J Neuroimmunol. 2006 Oct;179(1-2):152-62. doi: 10.1016/j.jneuroim.2006.07.004. Epub 2006 Aug 30. J Neuroimmunol. 2006. PMID: 16945426

9

Human vascular endothelial cells express functional nicotinic acetylcholine receptors.

Macklin KD, Maus AD, Pereira EF, Albuquerque EX, Conti-Fine BM. Macklin KD, et al. Among authors: conti fine bm. J Pharmacol Exp Ther. 1998 Oct;287(1):435-9. J Pharmacol Exp Ther. 1998. PMID: 9765366

10

Susceptibility of HLA DR3 transgenic mice to experimental autoimmune myasthenia gravis.

Raju R, Zhan WZ, Karachunski P, Sieck GC, Conti-Fine BM, David CS. Raju R, et al. Among authors: conti fine bm. Ann N Y Acad Sci. 1998 May 13;841:360-4. doi: 10.1111/j.1749-6632.1998.tb10947.x. Ann N Y Acad Sci. 1998. PMID: 9668259 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results